The Senate health committee will hold a hearing on the controversial 340B drug discount program on Thursday (March 15), and while the hearing notice says lawmakers will hear different perspectives on the program, it doesn't specify who will testify. The House Energy & Commerce Committee held a number of hearings on 340B last year and released a report this year with recommendations on ways to improve the program, but there were no 340B-specific hearings in the Senate in 2017. However,...